@Onnil5
Account based inBrazil
About this account
- Account based in
- Brazil
- Connected via
- Brazil Android App
Account-level information from X, not a live location or the device used for a specific post.
Cabo Frio
Joined July 2009
- Tweets77.7K
- Following16.2K
- Followers19.6K
- Likes58.5K
Oi amigo, confira esta incrível ferramenta de IA gratuita para criar modelos 3D a partir de texto ou imagens!
#MeshyAI #3D #AI #AIart #generativeAI #gamedev
meshy.ai/?utm_source=twitter…
I’ve been creating with Tripo. Join through my invite to get 300 credits after your first model, plus referral pricing: Pro for $1 or Max for $18 after an eligible payment within 30 days.
Try it here:
#AI3D #GameDevelopment #3DArt studio.tripo3d.ai/?utm_sourc…
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease.
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs access to experimental treatments. Thank you for your attention and compassion.
Onil retweeted
Lito Sousa: Ministro da Saúde diz estar 'em contato' com responsáveis por estudos de tratamentos experimentais oglobo.globo.com/saude/notic…
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa (@avioesemusicas) from Brazil in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs it!
Onil retweeted
Hi, @ionispharma, @broadinstitute, @harvard, @mayoclinic: please consider including Lito Sousa in the ION717 trial and the PRiSM trial (NCT07444580) for prion diseases. He was recently diagnosed with Creutzfeldt-Jakob disease and urgently needs access to experimental treatments.
Onil retweeted
@ionispharma @broadinstitute @harvard
@mayoclinic: considerem incluir Lito Sousa (@avioesemusicas @lito) do Brasil no ensaio ION717 e no ensaio PRiSM (NCT07444580) para doenças priônicas. Ele foi recentemente diagnosticado com doença de Creutzfeldt-Jakob e precisa de ajuda!
Onil retweeted
Urgent appeal for Lito Sousa, fighting Creutzfeldt-Jakob disease. Please share this reel far and wide.
@ionispharma - lonis Pharmaceuticals -
ION717 trial
@broadinstitute - PRiSM trial (NCT07444580) @harvard
@mayoclinic
Urgent appeal for Lito Sousa, fighting Creutzfeldt-Jakob disease. Please share this reel far and wide. Make sure to tag these institutions who could include him in life-saving trials:
Cada segundo conta:
@ionispharma - lonis Pharmaceuticals -
ION717 trial
@broadinstitute - PRiSM trial (NCT07444580) @harvard
@mayoclinic
Every share and tag can make a difference. Time is critical.
Onil retweeted
🚨Apelo🙏🏻Urgente por Lito Sousa
@avioesemusicas
lutando contra a doença de Creutzfeldt-Jakob.
instagram.com/reels/DcZBm3Ej…
@isispharm
— lonis Pharmaceuticals - ION717 trial
@broadinstitute
- PRiSM trial (NCT07444580)
@Harvard
@MayoClinic
O influenciador Lito Sousa, diagnosticado com a doença de Creutzfeldt-Jakob (DCJ), fez um apelo público neste domingo (23) para ter acesso a um tratamento experimental desenvolvido por pesquisadores da Universidade Harvard, nos Estados Unidos. Em sua primeira aparição desde que a esposa anunciou o diagnóstico, Lito publicou um vídeo no Instagram falando em inglês e pedindo para ser submetido ao estudo. O influenciador, conhecido pelo canal "Aviões e Músicas", já perdeu boa parte dos movimentos e, recentemente, teve o quadro agravado com a perda parcial da visão. A família busca vaga no "PrP-targeting siRNA Safety & Mechanism Study (PRiSM)", conduzido pelo Broad Institute em parceria com Harvard e a UMass. O estudo, que testa o medicamento siRNA, recrutou 15 pacientes em abril. Mila Seidl, esposa de Lito, já havia pedido mobilização nas redes para conseguir a inclusão do marido na pesquisa.
Quer ajudar o Lito? Compartilhe este reel na sua rede e marque as instituições abaixo. Cada segundo conta:
📌 @ionis_pharma — Ionis Pharmaceuticals — ION717 trial
📌 @broadinstitute — PRiSM trial (NCT07444580)
📌 @harvard
📌 @mayoclinic
Onil retweeted
@ionispharma @broadinstitute @harvard @mayoclinic por favor, considerem incluir Lito Sousa(@avioesemusicas @lito) do Br no ensaio ION717 e no ensaio PRiSM (NCT07444580) para doenças crônicas.
Onil retweeted
@ionispharma, @broadinstitute, @harvard, @mayoclinic: por favor, considerem incluir Lito Sousa (@avioesemusicas @lito) do Brasil no ensaio ION717 e no ensaio PRiSM (NCT07444580) para doenças priônicas. Ele foi recentemente diagnosticado com doença de Creutzfeldt-Jakob ajuda.